Development and Evaluation of the Effectiveness of the SMART-HAND Protocol for Hand Rehabilitation in Patients With Rheumatoid Arthritis
2026年8月13日 更新者：Busra Turk、Istanbul University - Cerrahpasa
Rheumatoid arthritis (RA) frequently affects the hand and wrist, resulting in pain, reduced joint stability, impaired proprioception, muscle weakness, and limitations in daily activities.
Although conventional rehabilitation primarily focuses on range of motion and strengthening exercises, sensorimotor impairments such as proprioceptive deficits are often underaddressed.
The SMART-HAND (Sensory, Massage, Approximation, ROM, Training = Strengthening + Perturbation) protocol was developed as a structured, mechanism-based rehabilitation program to improve proprioception, joint stability, motor control, and hand function.
This randomized controlled trial aims to evaluate the effectiveness of the SMART-HAND protocol in individuals with RA by comparing its effects on hand function, proprioception, pain, dexterity, muscle strength, and functional performance with conventional rehabilitation and a control group.
調査の概要
状態
まだ募集していません
研究の種類
介入
入学 (推定)
132
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究連絡先
- 名前：Busra Turk, PT, MSc
- 電話番号：+905448744200
- メール：bsrgvn9@gmail.com
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
いいえ
説明
Inclusion Criteria:
- Participants will be 18 years of age or older.
- Participants will have a diagnosis of rheumatoid arthritis for at least five years.
- Participants will be referred by a rheumatologist.
- Participants will have been on a stable medication regimen for the past three months.
- Participants will have no history of diabetes mellitus.
- Participants will have no other conditions affecting sensory function.
- Participants will provide informed consent to participate in the study.
Exclusion Criteria:
- Individuals who have undergone hand surgery within the past six months.
- Individuals with a history of upper extremity fracture within the past six months.
- Individuals with other musculoskeletal pain conditions involving the muscles and/or joints.
- Individuals diagnosed with a neurological disease that may affect sensory or motor function.
- Individuals who are unable to fully cooperate with the assessment procedures.
- Individuals who have received corticosteroid treatment within the past month.
- Individuals diagnosed with another rheumatic disease.
- Pregnant women.
- Individuals who are illiterate.
Withdrawal/Discontinuation Criteria
- Participants who miss more than 10% of the intervention sessions will be excluded from the study.
- Participants who change their medication dosage or medication class during the study period will be excluded from the study.
- Participants will have the right to withdraw from the study at any time and for any reason.
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：SMART-HAND Protocol
Participants assigned to the SMART-HAND Protocol Group will receive a supervised 12-week hand rehabilitation program consisting of two 50-minute sessions per week (24 sessions in total).
The SMART-HAND protocol includes massage, sensory training, joint approximation, range of motion exercises, stretching, strengthening exercises, and perturbation-based stabilization training.
Exercise progression will be individualized according to participants' tolerance using the Borg Rating of Perceived Exertion scale and progressive resistance.
The intervention is designed to improve proprioception, sensorimotor integration, dynamic joint stability, muscle strength, and hand function.
|
The SMART-HAND Protocol is a supervised, mechanism-based hand rehabilitation program administered twice weekly for 12 weeks (24 sessions, 50 minutes per session).
The protocol consists of sensory training, massage, joint approximation, range of motion exercises, stretching, strengthening exercises, and perturbation-based stabilization training.
Exercise progression is individualized according to participants' tolerance using the Borg Rating of Perceived Exertion scale and progressive resistance.
The intervention is designed to improve proprioception, sensorimotor control, joint stability, muscle strength, and hand function.
|
|
アクティブコンパレータ：Conventional Hand Rehabilitation Group
Participants assigned to the Conventional Hand Rehabilitation Group will receive a supervised 12-week conventional hand exercise program consisting of two 50-minute sessions per week (24 sessions in total).
The program includes range of motion, stretching, and strengthening exercises.
Exercise intensity and progression will be individualized according to participants' tolerance using the Borg Rating of Perceived Exertion scale and progressive resistance.
The intervention primarily aims to improve joint mobility, muscle strength, and hand function.
|
Participants will receive a supervised conventional hand rehabilitation program twice weekly for 12 weeks (24 sessions, 50 minutes per session).
The program includes range of motion, stretching, and strengthening exercises.
Exercise intensity and progression will be individualized according to participants' tolerance using the Borg Rating of Perceived Exertion scale and progressive resistance.
|
|
アクティブコンパレータ：Usual Care + Education Group
Participants assigned to the Usual Care + Education Group will continue to receive their routine medical care and will attend a single educational session lasting approximately 20-30 minutes.
The education will include joint protection principles, ergonomic recommendations, and strategies for performing activities of daily living.
No supervised exercise program will be provided during the 12-week study period.
|
The SMART-HAND Protocol is a supervised, mechanism-based hand rehabilitation program administered twice weekly for 12 weeks (24 sessions, 50 minutes per session).
The protocol consists of sensory training, massage, joint approximation, range of motion exercises, stretching, strengthening exercises, and perturbation-based stabilization training.
Exercise progression is individualized according to participants' tolerance using the Borg Rating of Perceived Exertion scale and progressive resistance.
The intervention is designed to improve proprioception, sensorimotor control, joint stability, muscle strength, and hand function.
Participants will receive a single face-to-face education session lasting approximately 20-30 minutes.
The education will include information on joint protection techniques, ergonomic principles, energy conservation, and recommendations for performing activities of daily living.
Participants will continue their routine medical care throughout the study but will not receive a supervised exercise program.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Michigan Hand Outcomes Questionnaire (MHQ)
時間枠：Baseline, Week 4, Week 8, and Week 12 (Primary endpoint: change from baseline to Week 12)
|
The Michigan Hand Outcomes Questionnaire (MHQ) will be used to assess hand function, activities of daily living, pain, work performance, aesthetics, and patient satisfaction.
The primary endpoint is the change in the total MHQ score from baseline to Week 12.
|
Baseline, Week 4, Week 8, and Week 12 (Primary endpoint: change from baseline to Week 12)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Joint Position Sense (Proprioception)
時間枠：Baseline, Week 4, Week 8, and Week 12
|
Wrist, metacarpophalangeal (MCP), and proximal interphalangeal (PIP) joint proprioception will be assessed using a joint position reproduction test with a goniometer.
The mean absolute repositioning error from three trials will be recorded.
|
Baseline, Week 4, Week 8, and Week 12
|
|
Nine-Hole Peg Test
時間枠：Baseline, Week 4, Week 8, and Week 12
|
Hand dexterity will be assessed using the Nine-Hole Peg Test.
The average completion time of two trials for each hand will be recorded in seconds.
|
Baseline, Week 4, Week 8, and Week 12
|
|
Duruöz Hand Index
時間枠：Baseline, Week 4, Week 8, and Week 12
|
Hand functional disability will be evaluated using the Duruöz Hand Index.
Higher scores indicate greater disability.
|
Baseline, Week 4, Week 8, and Week 12
|
|
Pain Intensity
時間枠：Baseline, Week 4, Week 8, and Week 12
|
Pain intensity during rest, activity, and night will be assessed using a 10-cm Visual Analog Scale (VAS).
Higher scores indicate greater pain.
|
Baseline, Week 4, Week 8, and Week 12
|
|
Sensory Threshold
時間枠：Baseline, Week 4, Week 8, and Week 12
|
Cutaneous sensory threshold will be evaluated using Semmes-Weinstein monofilaments.
The thinnest monofilament perceived by the participant will be recorded.
|
Baseline, Week 4, Week 8, and Week 12
|
|
Grip Strength
時間枠：Baseline, Week 4, Week 8, and Week 12
|
Maximum hand grip strength will be measured using a Jamar dynamometer.
The average of three maximal contractions will be recorded in kilograms.
|
Baseline, Week 4, Week 8, and Week 12
|
|
Pinch Strength
時間枠：Baseline, Week 4, Week 8, and Week 12
|
Lateral pinch and three-jaw chuck pinch strength will be measured using a Baseline pinch gauge.
The average of three trials will be recorded in kilograms-force.
|
Baseline, Week 4, Week 8, and Week 12
|
|
Range of Motion
時間枠：Baseline, Week 4, Week 8, and Week 12
|
Active range of motion of the wrist and finger joints will be measured using standard goniometers and recorded in degrees.
|
Baseline, Week 4, Week 8, and Week 12
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
出版物と役立つリンク
研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。
一般刊行物
- Hamilton GF, McDonald C, Chenier TC. Measurement of grip strength: validity and reliability of the sphygmomanometer and jamar grip dynamometer. J Orthop Sports Phys Ther. 1992;16(5):215-9. doi: 10.2519/jospt.1992.16.5.215.
- Duruoz MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, Dougados M, Revel M. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol. 1996 Jul;23(7):1167-72.
- Oxford Grice K, Vogel KA, Le V, Mitchell A, Muniz S, Vollmer MA. Adult norms for a commercially available Nine Hole Peg Test for finger dexterity. Am J Occup Ther. 2003 Sep-Oct;57(5):570-3. doi: 10.5014/ajot.57.5.570.
- Chua M, Seth I, Rozen WM. The reliability and applicability of the Ten Test in hand injuries: A systematic review. Hand Ther. 2024 Jun;29(2):44-51. doi: 10.1177/17589983241230249. Epub 2024 Jan 28.
- Jerosch-Herold C. Assessment of sensibility after nerve injury and repair: a systematic review of evidence for validity, reliability and responsiveness of tests. J Hand Surg Br. 2005 Jun;30(3):252-64. doi: 10.1016/j.jhsb.2004.12.006.
- Hillier S, Immink M, Thewlis D. Assessing Proprioception: A Systematic Review of Possibilities. Neurorehabil Neural Repair. 2015 Nov-Dec;29(10):933-49. doi: 10.1177/1545968315573055. Epub 2015 Feb 23.
- Lewis E, Fors L, Tharion WJ. Interrater and intrarater reliability of finger goniometric measurements. Am J Occup Ther. 2010 Jul-Aug;64(4):555-61. doi: 10.5014/ajot.2010.09028.
- Carter TI, Pansy B, Wolff AL, Hillstrom HJ, Backus SI, Lenhoff M, Wolfe SW. Accuracy and reliability of three different techniques for manual goniometry for wrist motion: a cadaveric study. J Hand Surg Am. 2009 Oct;34(8):1422-8. doi: 10.1016/j.jhsa.2009.06.002. Epub 2009 Aug 22.
- Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003 Sep;4(7):407-14. doi: 10.1016/s1526-5900(03)00716-8.
- Oksuz C, Akel BS, Oskay D, Leblebicioglu G, Hayran KM. Cross-cultural adaptation, validation, and reliability process of the Michigan Hand Outcomes Questionnaire in a Turkish population. J Hand Surg Am. 2011 Mar;36(3):486-92. doi: 10.1016/j.jhsa.2010.11.016. Epub 2011 Feb 4.
- Riemann BL, Lephart SM. The sensorimotor system, part I: the physiologic basis of functional joint stability. J Athl Train. 2002 Jan;37(1):71-9.
- Roijezon U, Clark NC, Treleaven J. Proprioception in musculoskeletal rehabilitation. Part 1: Basic science and principles of assessment and clinical interventions. Man Ther. 2015 Jun;20(3):368-77. doi: 10.1016/j.math.2015.01.008. Epub 2015 Jan 29.
- Young A, Dixey J, Cox N, Davies P, Devlin J, Emery P, Gallivan S, Gough A, James D, Prouse P, Williams P, Winfield J. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford). 2000 Jun;39(6):603-11. doi: 10.1093/rheumatology/39.6.603.
- Shauver MJ, Chung KC. The minimal clinically important difference of the Michigan hand outcomes questionnaire. J Hand Surg Am. 2009 Mar;34(3):509-14. doi: 10.1016/j.jhsa.2008.11.001.
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (推定)
2026年10月1日
一次修了 (推定)
2027年12月28日
研究の完了 (推定)
2027年12月30日
試験登録日
最初に提出
2026年8月5日
QC基準を満たした最初の提出物
2026年8月7日
最初の投稿 (実際)
2026年8月10日
学習記録の更新
投稿された最後の更新 (実際)
2026年8月14日
QC基準を満たした最後の更新が送信されました
2026年8月13日
最終確認日
2026年8月1日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- IstanbulUC-FTR-BT-02
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
いいえ
IPD プランの説明
Individual participant data will not be made publicly available.
Data will be retained by the investigators in accordance with institutional policies and ethical approval, and no current plan exists for external data sharing.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。